Foundry Partners, LLC Biogen Inc. Transaction History

Foundry Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$256.56 - $292.34 $1.93 Million - $2.2 Million	7,511 Added 13.12%	64,753 $18 Million
Q4 2022 Jan 30, 2023	BUY	$252.44 - $306.72 $3.88 Million - $4.71 Million	15,360 Added 36.67%	57,242 $15.9 Million
Q3 2022 Oct 21, 2022	BUY	$194.69 - $268.46 $8.15 Million - $11.2 Million	41,882 New	41,882 $11.2 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.